The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: November 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

11. MYC determines lineage commitment in KRAS-driven primary liver cancer development

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next

D’Artista, L. et al. Journal of Hepatology. 79(1):141-149 (2023).
doi: 10.1016/j.jhep.2023.02.039.

Summary, future impact and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

In this paper, D’Artista et al are investigating both the “cell of origin” and the molecular mechanisms that govern the development of primary tumours in the liver. Building upon previous work demonstrating that hepatocytes pose increased plasticity, the authors implicate MYC as a master regulator in lineage commitment in primary liver cancer. More exactly, the authors of this paper suggest that high MYC levels and MYC controlled transcriptional activity of FOXA1, FOXA2 and ETS1 can determine the commitment of malignant hepatocytes towards hepatocellular carcinoma. The overexpression of Ets1 together with shRNA targeting Foxa1 and Foxa2 in MYC transformed hepatocytes caused a switch from hepatocellular carcinoma to intrahepatic cholangiocarcinoma development (as shown in the Figure).

Future impact

The authors highlight the relevance of their findings for regenerative medicine and modulation of cancer response to treatment.

Read more in Journal of Hepatology

 

11. MYC determines lineage commitment in KRAS-driven primary liver cancer development

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: December 2025

December 8, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship
News

Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship

February 2, 2026
“Instrumental during my PhD journey”: Àlex Cebrià Xart’s EACR Travel Fellowship
Community

“Instrumental during my PhD journey”: Àlex Cebrià Xart’s EACR Travel Fellowship

January 30, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR